Following her Award Lecture, ‘Progress and Challenges in Clinical Cancer Genetics’, Judy Garber further discusses this topic at the ASCO 2019 annual meeting. The progress made in genetic testing and the benefits/challenges that remain are covered.
Questions
1. What progress has been made in genetic testing for cancer susceptibility among individuals at high genetic risk, and what challenges remain? (0:03)
2. How are inherited genetics informing target therapy? (01:21)
3. What other challenges in clinical cancer genetics do you consider important? (02:40)
Speaker disclosure: Judy Garber has nothing to disclose in relation to this video interview.
Filmed at the American Society of Clinical Oncology (ASCO) 2019 Annual Meeting, Chicago, IL, USA.
